Terms: = Ovarian cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2 AND Prognosis
5 results:
1. Anlotinib Inhibits ovarian cancer and Enhances Cisplatinum Sensitivity
Xu X; Wang Q; Shen L; Shen Y; Liu H; Liu Y; Yang Z; Hoffman RM; Feng W
Anticancer Res; 2024 Apr; 44(4):1399-1407. PubMed ID: 38538004
[TBL] [Abstract] [Full Text] [Related]
2.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
3. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating notch2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Devor EJ; Miecznikowski J; Schickling BM; Gonzalez-Bosquet J; Lankes HA; Thaker P; Argenta PA; Pearl ML; Zweizig SL; Mannel RS; Brown A; Ramirez NC; Ioffe OB; Park KJ; Creasman WT; Birrer MJ; Mutch D; Leslie KK
Gynecol Oncol; 2017 Dec; 147(3):648-653. PubMed ID: 28969912
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
Chen C; Wang X; Huang S; Wang L; Han L; Yu S
Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
[TBL] [Abstract] [Full Text] [Related]
5. Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer.
Zhou X; Teng L; Wang M
Tumour Biol; 2016 May; 37(5):6979-85. PubMed ID: 26662955
[TBL] [Abstract] [Full Text] [Related]
